Status and phase
Conditions
Treatments
About
The main purposes of this study are to describe the pharmacodynamic effects, safety and pharmacokinetics of a single dose of sarilumab.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Note: The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial therefore not all inclusion/ exclusion criteria are listed.
Primary purpose
Allocation
Interventional model
Masking
105 participants in 4 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal